![Sunil Karnawat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sunil Karnawat
Corporate Officer/Principal bij
REZOLUTE, INC.
Vermogen: 117 671 $ op 30-09-2026
Profiel
Sunil Karnawat currently works at Rezolute, Inc., as Chief Commercial Officer from 2025.
Dr. Karnawat also formerly worked at Cytokinetics, Inc., as Vice President and Ultragenyx Pharmaceutical, Inc., as Vice President.
Dr. Karnawat received his graduate degree and doctorate degree from North Dakota State University, undergraduate degree from College of Engineering, Pune, and Masters Business Admin degree from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
REZOLUTE, INC. 0,03% | 21-09-2026 | 28.423 ( 0,03% ) | 117 671 $ | 30-09-2026 |
Actieve functies van Sunil Karnawat
| Bedrijven | Functie | Begin |
|---|---|---|
| REZOLUTE, INC. | Corporate Officer/Principal | 18-08-2025 |
Eerdere bekende functies van Sunil Karnawat
| Bedrijven | Functie | Einde |
|---|---|---|
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | - |
| CYTOKINETICS, INCORPORATED | Corporate Officer/Principal | - |
Opleiding van Sunil Karnawat
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
13
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
Ultragenyx Pharmaceutical, Inc.
 Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
North Dakota State University
 North Dakota State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
College of Engineering, Pune
 College of Engineering, Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rezolute, Inc.
 Rezolute, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for metabolic diseases related to chronic glucose imbalance | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
